Kristian Brock

Birmingham, ENG B152TT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Efficacy and optimal dose of acetic acid for treating colonised burns wounds (AceticA): a double-blind, single Centre, randomised, controlled phase II trial.

Efficacy and optimal dose of acetic acid for treating colonised burns wounds (AceticA): a double-blind, single Centre, randomised, controlled phase II trial.

Journal: Journal of burn care & research : official publication of the American Burn Association

Published: July 24, 2025

Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial.

Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial.

Journal: BMJ open

Published: February 26, 2025

Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs.

Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs.

Journal: Biometrics

Published: February 22, 2024

Efficacy and optimal dose of acetic acid to treat colonised burns wounds: protocol for a pilot randomised controlled trial.

Efficacy and optimal dose of acetic acid to treat colonised burns wounds: protocol for a pilot randomised controlled trial.

Journal: BMJ open

Published: September 25, 2023

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension.

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension.

Journal: Cephalalgia : an international journal of headache

Published: September 04, 2023

A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial.

A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial.

Journal: PloS one

Published: August 31, 2023

Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension.

Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension.

Journal: Eye (London, England)

Published: August 11, 2023

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial.

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial.

Journal: BMC medical research methodology

Published: July 12, 2023

Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT).

Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT).

Journal: Translational vision science & technology

Published: May 01, 2023

A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension.

A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertension.

Journal: Headache

Published: February 05, 2023

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial.

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial.

Journal: Brain : a journal of neurology

Published: September 05, 2022

A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials.

A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials.

Journal: Pharmaceutical statistics

Published: July 28, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026